Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-16

Clinical Trial Update: Fault Detection, Zone MPC and DiAs System in T1D [NA]

View source ↗

Summary

Clinical trial update on fault detection, Zone MPC, and the DiAs system for managing Type 1 Diabetes. Sponsored by Rensselaer Polytechnic Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rensselaer Polytechnic Institute | Conditions: Type 1 Diabetes | NA | Status: UNKNOWN